Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06225830 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 1 of 1 entry Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 13 participants (planned 24)
    • Primary and study completion dates changed from estimate of Sep 2026 to Aug 24, 2026
    • Eligibility criteria expanded, about 27 words
    • Secondary endpoints: details revised at 6 of 6 entries
  2. Enrollment closed, study ongoing
    • Primary and study completion pushed from Jun 2026 to Sep 2026
    • Site details revised
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 2024 to Jun 2026
    • Start date changed from estimate of Feb 2024 to Jun 4, 2024
    • Site details revised
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to see how well therapy with the Eksobionic Exoskeleton (Esko) works for people with Parkinson's disease (PWPD). Esko is a robotic device that provides high repetition and intensity training. The investigators will examine its impact on walking, balance, and quality of life before, during and after an eight-week intervention program. The results will lay the groundwork for future trials, potentially leading to long-term improvements in mobility and quality of life for PWPD.
Trial Details
NCT Number NCT06225830
Lead Sponsor Albert Einstein Healthcare Network
Collaborators: Moss Rehabilitation Research Institute
Conditions
(from sponsor)		 Parkinson Disease
Related terms Parkinson Disease
Enrollment 13 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov